Participate in the Grant for Multiple Sclerosis Innovation (GMSI)

Who is eligible to apply for the GMSI?

Academic researchers from around the world may apply for the innovation grant if they are involved in innovative translational research projects associated with the following:

  • Multiple sclerosis (MS) pathogenesis
  • Prediction of MS subtypes
  • Identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments
  • Any potential new treatments

Applicants must be aware that to be eligible to apply they must have preliminary data (data will be requested as part of the application procedure).

Unsuitable research projects:
The research proposed for the Grant for Multiple Sclerosis Innovation:

  • Must not involve any of Merck’s/EMD Serono's products 
  • Must not involve interventional clinical research 
  • Must not involve the testing of competitive products.